Cent Eur J Public Health 2020, 28(4):297-301 | DOI: 10.21101/cejph.a5237

Influenza vaccination rate among high risk group patients in primary health care in Greece

Anastasia Papaioannou1,2, Apostolia-Evangelia Konstantinidi2, Ekaterini Primikiri2, Foteini Asimakopoulou2, Dimitrios Aravantinos2, Zacharoula Mavromichali2
1 Health Centre of Nea Makri, Athens, Greece
2 Health Centre of Kapandriti, Athens, Greece

Objective: Seasonal influenza vaccination is the main method for influenza prevention. The main objective of this study is to estimate the frequency of vaccinations in patients with chronic illnesses presented to a primary health care (PHC) centre.

Methods: This cross-sectional study was performed in patients admitted to the Kapandriti Health Centre. Their vaccination status with an influenza vaccine and their underlying diseases were recorded.

Results: 34.8% of the subjects had been vaccinated against seasonal influenza. Vaccination coverage was found to be 53.9% in pulmonary, 55.6% in chronic kidney disease, 43.7% in cardiovascular disorders, 40.6% in diabetes, 40.6% in any kind of malignancy, and finally 33.3% in neurological patients. The most significant predictors for vaccination were the age group of 60 to 79 years (OR = 3.08, 95% CI: 1.79-5.29), age over 80 years (OR = 2.91, 95% CI: 1.58-5.36), respiratory disease (OR = 2.25, 95% CI: 1.33-3.76), cardiovascular disorder (OR = 1.46, 95% CI: 1.02-2.10), and 3 to 5 visits to the unit annually (OR = 1.57, 95% CI: 1.12-2.24). Finally, it was discovered that coexistence of one to three diseases reduced the likelihood ratio for vaccine uptake (OR = 0.15, 95% CI: 0.03-0.79, p < 0.05).

Conclusions: The influenza vaccination rate for the population of the present study has been found higher than that reported previously in literature. We believe that there is a need to implement new and more effective strategies such as educating vulnerable groups on the benefits of vaccination and so reducing the incidence of influenza and its complications especially in vulnerable groups.

Keywords: influenza, vaccination, high risk group, primary healthcare, Greece

Received: October 22, 2017; Revised: August 11, 2020; Accepted: August 11, 2020; Published: December 18, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Papaioannou A, Konstantinidi A, Primikiri E, Asimakopoulou F, Aravantinos D, Mavromichali Z. Influenza vaccination rate among high risk group patients in primary health care in Greece. Cent Eur J Public Health. 2020;28(4):297-301. doi: 10.21101/cejph.a5237. PubMed PMID: 33338366.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Sessa A, Rossi A, Cricelli I. Adult immunization schedule. The general practitioner's perspective and new tools for better practice. J Prev Med Hyg. 2015;56(1):E9-11. Go to PubMed...
    2. World Health Organization. Influenza seasonal. Fact sheet no. 211 [Internet]. Geneva: WHO; 2003 [cited 2017 Sep 6]. Available from: http://www.who.int/mediacentre/factsheets/2003/fs211/en/.
    3. Nicoll A, Ciancio B, Tsolova S, Blank P, Yilmaz C. The scientific basis for offering seasonal influenza immunisation to risk groups in Europe. Euro Surveill. 2008;13(43):19018. doi: 10.2807/ese.13.43.19018-en. Go to original source... Go to PubMed...
    4. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):36-44. Go to original source... Go to PubMed...
    5. World Health Organization. Seasonal vaccination policies and coverage in the European Region [Internet]. Geneva: WHO; 2014 [cited 2017 Sep 6]. Available from: http://www.euro.who.int/en/health-topics/communicable-diseases/influenza/vaccination/seasonal-vaccination-policies-and-coverage-in-the-european-region.
    6. Ohmit SE, Thompson MG, Petrie JG, Thaker SN, Jackson ML, Belongia EA, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis. 2014;58(3):319-27. Go to original source... Go to PubMed...
    7. Kissling E, Valenciano M, Buchholz U, Larrauri A, Cohen JM, Nunes B, et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season2012/13. Euro Surveill. 2014;19(6):20701. doi: 10.2807/1560-7917.es2014.19.6.20701. Go to original source... Go to PubMed...
    8. Georgakopoulou T, Menegas D, Katsioulis A, Theodoridou M, Kremastinou J, Hadjichristodoulou C. A cross-sectional vaccination coverage study in preschool children attending nurseries-kindergartens: implications on economic crisis effect. Hum Vaccin Immunother. 2017;13(1):190-7. Go to original source... Go to PubMed...
    9. Warner JG, Portlock J, Smith J, Rutter P. Increasing seasonal influenza vaccination uptake using community pharmacies: experience from the Isle of Wight, England. Int J Pharm Pract. 2013;21(6):362-7. Go to original source... Go to PubMed...
    10. Isenor JE, Killen JL, Billard BA, McNeil SA, MacDougall D, Halperin BA, et al. Impact of pharmacists as immunizers on influenza vaccination coverage in the community-setting in Nova Scotia, Canada: 2013-2015. J Pharm Policy Pract. 2016;9:32. doi: 10.1186/s40545-016-0084-4. Go to original source... Go to PubMed...
    11. Arabyat RM, Raisch DW, Bakhireva L. Influenza vaccination for patients with chronic obstructive pulmonary disease: implications for pharmacists. Res Social Adm Pharm. 2018;14(2):162-9. Go to original source... Go to PubMed...
    12. Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35(2):121-6. Go to original source... Go to PubMed...
    13. Leval A, Hergens MP, Persson K, Örtqvist Å. Real-time real-world analysis of seasonal influenza vaccine effectiveness: method development and assessment of a population-based cohort in Stockholm County, Sweden, seasons 2011/12 to 2014/15. Euro Surveill. 2016;21(43):30381. doi: 10.2807/1560-7917.ES.2016.21.43.30381. Go to original source... Go to PubMed...
    14. Nitsch-Osuch A, Wardyn K. Influenza vaccine coverage in age-related risk groups in Poland, 2004-2007. Cent Eur J Public Health. 2009;17(4):198-202. Go to original source... Go to PubMed...
    15. Astray-Mochales J, de Antres AL, Hemandez-Barrera V, Rodriguez-Rieiro C, Garrido PC, Esteban-Vasallo MD, et al. Influenza vaccination coverages among high risk subjects and health care workers in Spain. Results of two consecutive National Health Surveys (2011-2014). Vaccine. 2016;34(41):4898-904. Go to original source... Go to PubMed...
    16. Lytras T, Kossyvakis A, Melidou A, Andreopoulou A, Exindari M, Gioula G, et al. Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test negative study. Vaccine. 2015;33(2):367-73. Go to original source... Go to PubMed...
    17. National Center for Health Statistics. Healthy people 2010: general data issues [Internet]. CDC; 2015 [cited 2017 Sep 6]. Available from: https://www.cdc.gov/nchs/data/hpdata2010/hp2010_general_data_issues.pdf.
    18. Kunze U, Kunze M. The Austrian vaccinationparadox: tick-borne encephalitis vaccination versus influenza vaccination. Cent Eur J Public Health. 2015;23(3):223-6. Go to original source... Go to PubMed...
    19. Norris T, Vahratian A, Cohen RA. Vaccination coverage among adults aged 65 and over: United States, 2015. NCHS Data Brief. 2017;(281):1-8.
    20. Marshall E, Salmon D, Bousfiha N, Togola Y, Ouedraogo F, Santantonio M, et al. Vaccination coverage among social and healthcare workers in ten countries of Samu-social international sites. Vaccine. 2017;35(39):5291-6. Go to original source... Go to PubMed...
    21. Fabiani M, Riccardo F, Di Napoli A, Gargiulo L, Declich S, Petrelli A. Differences in influenza vaccination coverage between adult immigrants and Italian citizens at risk for influenza-related complications: a cross-sectional Study. PLoS One. 2016;11(11):e0166517. doi: 10.1371/journal.pone.0166517. Go to original source... Go to PubMed...
    22. Sutcliffe K, Kilgore PE, DeHoff K, Evans R, Kaye KS, Malosh RE, et al. Survey of vaccination knowledge and acceptance among adults admitted to an urban emergency department. Vaccine. 2017;35(8):1148-51. Go to original source... Go to PubMed...
    23. Burns VE, Ring C, Carroll D. Factors influencing influenza vaccination uptake in an elderly, community-based sample. Vaccine. 2005;23(27):3604-8. Go to original source... Go to PubMed...
    24. Pearson WS, Dube SR, Ford ES, Mokdad AH. Influenza and pneumococcal vaccination rates among smokers: data from the 2006 Behavioral Risk Factor Surveillance System. Prev Med. 2009;48(2):180-3. Go to original source... Go to PubMed...
    25. Nitsch-Osuch A, Gołębiak I, Wyszkowska D, Rosińska R, Kargul L, Szuba B, et al. Influenza vaccination coverage among Polish patients with chronic diseases. Adv Exp Med Biol. 2017;968:19-34. Go to original source... Go to PubMed...
    26. Lu PJ, O'Halloran A, Ding H, Srivastav A, Williams WW. Uptake of influenza vaccination and missed opportunities among adults with high-risk conditions, United States, 2013. Am J Med. 2016;129(6):636.e1-636.e11. doi: 10.1016/j.amjmed.2015.10.031. Go to original source... Go to PubMed...
    27. Yang TU, Song JY, Noh JY, Cheong HJ, Kim WJ. Influenza and pneumococcal vaccine coverage rates among patients admitted to a teaching hospital in South Korea. Infect Chemother. 2015;47(1):41-8. Go to original source... Go to PubMed...
    28. Sypsa V, Livanios T, Psichogiou M, Malliori M, Tsiodras S, Nikolakopoulos I, et al. Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey. Euro Surveill. 2009;14(49):19437. doi: 10.2807/ese.14.49.19437-en. Go to original source... Go to PubMed...
    29. Dáňová J, Šálek J, Kocourková A, Čelko AM. Factors associated with parental refusal of routine vaccinationin the Czech Republic. Cent Eur J Public Health. 2015;23(4):321-3. Go to original source... Go to PubMed...
    30. Mangtani P, Shah A, Roberts J. Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect. 2007;135(1):139-43. Go to original source... Go to PubMed...

    Return to the content